U.S. senator Rand Paul (R-KY) introduces legislation to streamline the approval process for biosimilars by eliminating costly and redundant clinical s...
An address to FDA staff at the White Oak, MD campus by HHS secretary Robert F. Kennedy Jr. diverts to Deep State rhetoric and accusations about agency...
Daxor Corp. submits a 510(k) seeking FDA clearance for its next-generation blood volume analyzer.
A bipartisan group of Senate and House members introduce legislation to advance research into brain cancer and improve care for brain cancer patients.
FDA says it intends to phase out animal testing in the development of monoclonal antibodies and some other drugs.
Hundreds of U.S. biomedical innovators and investors urge the Senate to help restore critical FDA staff that were recently laid off so that institutio...
Johnson & Johnson reports new icotrokinra (JNJ-2113) data from a Phase 3 studys subgroup analysis in moderate-to-severe plaque psoriasis patients.
